Two Cases of Subcutaneous Tuberculous Granuloma Associated with BCG Vaccination. 2020

Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
Department of Dermatology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. kigawa.tadayuki.g@tokai.ac.jp.

In recent years, BCG vaccination is routinely performed worldwide. The Ministry of Health, Labor and Welfare of Japan reported that the vaccination rate was as high as 92.9% in 2011. Majority of the reported local adverse reactions to BCG vaccination included lymph node swelling, keloid formation, and abscesses. Subcutaneous tuberculous granuloma is a rare local adverse reaction to BCG vaccination. Herein, we report two cases of developing subcutaneous tuberculous granuloma associated with BCG vaccination. Both of them were treated with isoniazid. There is no standard management for BCG-induced subcutaneous tuberculous granuloma, however, treatment with anti-tuberculosis drugs should be considered for cases of BCGinduced subcutaneous tuberculous granuloma with abscesses or ulcerations.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D005260 Female Females
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D014382 Tuberculosis, Cutaneous Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS. Scrofuloderma,Skin Tuberculosis,Tuberculid

Related Publications

Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
September 1952, Ugeskrift for laeger,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
October 1952, Ugeskrift for laeger,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
January 1955, Portugal medico,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
April 1967, Kangogaku zasshi,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
April 2001, Annales de dermatologie et de venereologie,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
January 1953, Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
April 1967, Kangogaku zasshi,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
July 1990, Der Radiologe,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
November 1961, The American review of respiratory disease,
Tadayuki Kigawa, and Mayu Kawai, and Hanako Yamaoka, and Akio Kondoh, and Masahiro Tojo, and Tomotaka Mabuchi
October 1970, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!